Are Azithral 500 and azithromycin 500 the same?
Azithral 500 is a brand name for azithromycin 500 mg. In practice, if both products state “azithromycin 500 mg,” they deliver the same active ingredient at the same strength, so the medication is the same drug even if the brand differs.
What’s different if the active ingredient is the same?
Even when the active ingredient and dose match, differences can come from non-active formulation details such as excipients (the tablet’s other ingredients). Those differences can affect things like how the tablet feels in the mouth, how fast it dissolves, and sometimes tolerance for some patients. The clinical effect should be similar because the active drug is the same.
Can I switch between them?
Yes, switching between a brand and its corresponding generic is typically acceptable when the dose and formulation strength match (for example, both are azithromycin 500 mg tablets). The main reason not to switch is if a product is a different dosage form (for example, suspension vs tablet) or if you were told to use a specific formulation for a reason.
When would “Azithral 500 vs azithromycin 500” matter clinically?
The comparison usually matters less than dosing instructions. What matters most is:
- the prescribed dose and duration
- the infection being treated
- allergies (especially to macrolide antibiotics)
- drug interactions (some medicines interact with azithromycin)
- kidney or liver issues and other safety factors
How to verify you’re getting the right one
Check the label for:
- “azithromycin” as the active ingredient
- “500 mg” strength
- tablet form (if you’re comparing tablets)
If Azithral 500 doesn’t list azithromycin 500 mg clearly, then the comparison is no longer a straight “brand vs generic” match.
Are there patent or pricing differences?
If you’re asking about cost or brand availability, pricing can differ between a branded product (like Azithral) and generics of azithromycin 500 mg. For drug-specific patent/exclusivity tracking, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/
Sources:
1. https://www.drugpatentwatch.com/